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This research describes a unique, effective and inexpensive delivery system to provide discrete quantities of drugs on a chronic 
basis to the inner ear. The amount of the drug administered and specific timing of each administration are under investigator 
control. A micro-injection system mounted atop an animal's head is shown to permit repeated application of agents which 
effectively block neural responsiveness (tetrodotoxin) on a daily basis for periods up to 2 weeks. Cannulation of the inner ear and 
chronic delivery of control substances (artificial perilymph) do not affect function. This system may be used to administer drugs to 
other compartments of the body (e.g., the brain) on a chronic basis for neurophysiologic and neuropharmacologic investigations. 
Introduction 
Studies of the effects of chronic local drug 
application to the cochlea have been hindered by 
the relative inaccessibility, of the temporal bone. 
In acutely prepared animals, investigators have 
successfully studied the physiological and histo- 
logical effects of drugs applied locally on the 
cochlea and from these studies provided insights 
into local mechanisms and membrane character- 
istics of inner ear tissue. One technical approach 
was the perfusion of agents in a solution of artifi- 
cial perilymph through the scalae (Nuttall et al., 
1977; Mori et al., 1986; Ryan et al., 1987). This 
method guarantees reasonably even distributiorr 
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of the drug through the cochlea and relatively 
fast elimination of the drug. In other experi- 
ments, drugs have been introduced into the 
cochlea via the round window (Lundman et al., 
1987; Morizono et al., 1987; Schachern et al., 
1987; Sillman, et al., 1989; Ohls6n et al., 1991). 
For chemicals with low molecular weights (less 
than 400 Da) an agent applied on the round 
window quickly diffuses into the scala tympani 
and, in time, will reach the apex and modiolus of 
the cochlea. With this method, the time and 
concentration of drug distribution along the 
cochlea may be variable; however, no direct 
anatomical changes are induced into the scalae. 
In addition, injection of a solution directly into 
the scala tympani through the round window and 
cannulation of the round window has been used 
reliably. If only small volumes are infused, only 
minor changes are made in the perilymph compo- 
sition and doses may be accurately controlled 
(Kaplan et al., 1983; Born et al., 1988). 
For many experimental questions multiple and 
long-term drug applications are required. For ex- 
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ample, in studies of tetrodotoxin (TTX)-induced 
suppression of auditory nerve action potentials, 
the peripheral and central effects of prolonged 
deprivation for days or weeks would be of signifi- 
cant interest. Techniques developed for acute 
drug applications are unsuitable for long-term 
drug applications due to the requirement of re- 
peated anesthesia and potential infection that 
accompany continued or re-exposure of the 
cochlea. To avoid some of these complications 
and accomplish a long-term drug effect, Pasic and 
Rubel (1989) used Elvax disks that were impreg- 
nated with TTX. These disks, positioned on the 
round window, slowly released TTX on the sur- 
face of the membrane  allowing diffusion into the 
perilymph. This technique was shown to release 
the T-I'X continuously for a 2-day period. Changes 
in size and T I ' X  concentration of the disks may 
lengthen the time over which the agent is re- 
leased; but based upon our own observations, its 
ability to cause auditory nerve blockade appears  
limited to a maximum of 4 -5  days. 
Cannulae chronically implanted into the tym- 
panic bulla have been used in cats for chronic 
local drug administration to the surface of the 
inner ear and, hence, hopefully into the inner 
ear. Igarashi and Suzuki (1985) injected chlorhex- 
idine into the middle ear three times over a 6-day 
period. Diffusion from the middle ear into the 
cochlea led to a chronic application of the agent 
tO the inner ear. However, this technique does 
not yield precise control over the amount of the 
agent introduced into the inner ear. 
For many studies of local drug effects an im- 
plantable osmotic pump (e.g., ALZET,  mini- 
series, A L Z A  Corp, Palo Alto, CA) with a small 
cannula can provide a means to introduce small, 
controlled quantities of an agent into the inner 
ear (personal observation) or other sites of the 
body (e.g., Friedman and Shatz, 1990). These 
devices have been in use for some years 
(Theeuwes and Yum, 1976), and have the advan- 
tages of simplicity, total implantability, reliability, 
and commercial availability. The disadvantage of 
these devices is that they do not permit irregular 
intervals or doses of drug administration, nor the 
ability to stop and restart drug administration 
under experimenter  control. For many studies the 
ability to assess recovery, permanent  drug effect, 
and to repeatedly examine the effects of an agent 
or different quantities of an agent, are necessary. 
In the present article, we describe and discuss 
an infusion system that is capable of infusing 
multiple dosages of a drug in the guinea pig 
cochlea over a longer period of time. This system 
allows multiple infusions directly into the scala 
tympani of very small amounts of solutions, the 
volume of which can be varied from injection to 
injection; and the time of administration is under 
control of the investigator. 
Fig. 1. A: syringe tip and plunger with screw placement for construction of the micro-infusion system body. B: micro-infusion 
system (MIS) with cannula attached to infusion reservoir. 
Materials and methods 
A micro-infusion system (MIS) was designed 
for implantation into the guinea pig cochlea. We 
used Hartley strain guinea pigs between 250 and 
500 g. The MIS consists of 2 major parts: the 
micro-injector with screw mechanism for regula- 
tion of volume of solution infused, which was 
anchored to the skull; and the catheter system 
with infusion tip, which was implanted into the 
scala tympani. 
Materials and fabrication 
The body of the micro-injector was made from 
the end of a 1-ml 26G 3 /8  in. tuberculin syringe 
(Becton Dickinson and Company, Rutherford). 
The plunger was removed and the first 0.5 cm of 
the needle holder tip and 'back' 5.8 cm of the 
syringe body (from the 0.25 ml mark) were cut off 
and discarded. This left a section of the syringe 
body that was 1.5 cm in length from just behind 
the tip. This functioned as the body of the micro- 
injector (see Fig. 1A). The rubber tip of the 
plunger was saved. A no. 4-40 × 1/2 in. stainless 
steel screw with hex nut (Small Parts, Inc., Mi- 
ami, FL) was then screwed into the hole of the 
rubber plunger and locked in place with 
cyanoacrylate adhesive. The rubber plunger, with 
the screw and nut, was inserted into the syringe 
until the nut seated against the end of the syringe 
(Fig. 1B). The nut was fixed to the syringe with 
autoclavable plastic tape. Turning the screw de- 
pressed the plunger and, hence, injected small 
amounts of the solution. 
In order to accommodate the catheter, the 
diameter of the syringe tip was enlarged suffi- 
ciently using a small pin to permit introduction 
and partial insertion (about 3 mm) of a 6-cm 
length of (0.033 outer diameter, 0.014 inner diam- 
eter) micro-renathane tubing (Braintree Scien- 
tific, Inc.). This catheter was fixed into the sy- 
ringe tip with cyanoacrylate adhesive, taking care 
not to plug the catheter with glue. 
The infusion tip of the catheter was made 
from a 1.5-cm length of teflon coating insulation 
gently stripped from 5T Pt-Ir wire (A-M Systems, 
Inc., Everett, WA). This teflon tube was then 
carefully inserted in the distal end of the catheter 
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tube. A drop of liquid silicone rubber (Dow Corn- 
ing silastic elastomer and Dow Coming catalyst 
MDX 4-4210) was used to fix the teflon tube to 
the micro-renathane tubing. In addition, a tiny 
drop of silicone rubber was applied 0.5 mm from 
the end of the infusion tip. This silicone drop 
limited the extent to which the infusion tip could 
be introduced into the scala tympani. In addition, 
it helped seal the fistula created to introduce the 
cannula and provided a safe point to grasp the 
system during the implantation procedure. To 
enhance the hardening process of the silicon rub- 
ber, the catheter was baked in an oven at 70°C 
for 20 min. The cathether was then cleaned, 
checked for leakages by perfusing it with alcohol 
and distilled water, and autoclaved. Construction 
of the catheter and evaluation of the end product 
was performed with the aid of an operating mi- 
croscope. 
Implantation procedure 
Before implantation of the MIS, the injector 
was filled with the drug solution. This was accom- 
plished by first filling the body of the syringe with 
the drug solution, taking care to eliminate any 
trapped air bubbles. The syringe tip with the 
affixed catheter was then snapped onto the sy- 
ringe body. The injection screw was turned clock- 
wise until the solution appeared at the infusion 
tip. Then the tip of the catheter was placed in the 
solution and extra fluid was drawn into the injec- 
tor by turning the screw counterclockwise to fill 
the system to capacity. The total volume of the 
solution the MIS holds is approximately 0.125 ml. 
The implantation procedure was performed 
using aseptic surgical techniques and conformed 
to the Guidelines of Humane Animal Care. Sur- 
gical anesthesia was accomplished using ketamine 
(40 mg/kg, i.m.) xylazine (10 mg/kg, i.m.) and 
local infusion of 1% lidocaine. The animals were 
given prophylactic antibiotic injections prior to 
and following surgery (chloromycetin, 10 mg/kg, 
i.m.). The animal's skull was exposed via a mid- 
line incision and the periosteum was removed. 
Three no. 1-72 x 5 /6  in. stainless steel screws 
(Small Parts, Inc., Miami, FL) were self-tapped 
into holes drilled around the bregma. These al- 
lowed secure anchoring of the MIS to the skull 
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with methyl methacrylate. In addition, an in- 
verted no. 4-40 × 1 /2  in. stainless steel screw was 
affixed to the skull as a restraining bolt. A 
postauricular approach was used to expose the 
cochlea. The round window and basal turn of the 
cochlea were visualized and a small hole (0.1 mm 
in diameter) was drilled into the basal turn of the 
cochlea 2 mm anterior to the round window, 
allowing access to the scala tympani. 
With fine forceps holding the silicon drop, the 
infusion catheter was inserted into the hole in the 
lateral wall until the silicon drop was seated 
against the otic capsule. A small piece of muscle 
fascia was placed around the scala tympani defect 
and methyl methacrylate was used to fix the 
catheter in position at the bulla wall bony defect. 
The catheter and injector were then secured to 
the skull with additional methyl methacrylate. 
The bony defect in the bulla was covered with a 
small piece of tissue and the wound was closed 
with interrupted silk sutures. It was found helpful 
to fix the injector with the injection screw di- 
rected caudally, next to the restraining bolt. 
The MIS was tested in vitro and in vivo experi- 
ments. For in vivo testing a group of 29 guinea 
pigs was chronically implanted with the MIS into 
the scala tympani. Eight of these animals re- 
ceived daily injections of 0.5 /xl of saline, while 
the rest received daily 0.5-p,l injections of 25 tzM 
tetrodotoxin* in saline (TTX, a reversible 
sodium-channel blocker). These subjects received 
daily repeat  injections for 8-14  days. In vitro tests 
of the injector system evaluated the shrinkage of 
the MIS with sterilization, reliability of minimal 
dosing, and passive diffusion of catheter contents. 
The effectiveness of drug treatment  using the 
MIS was evaluated on the basis of evoked re- 
sponse in the auditory system, using the auditory 
brain-stem response (ABR) and middle latency 
response (MLR) as the criteria for evaluation. 
For these studies, evoked responses were 
recorded from an active epidural recording elec- 
trode placed over the vertex, and an indifferent 
* This dose was selected based upon acute studies as reliably 
and reversibly providing a more than 70-dB threshold shift 
in electrophysiological sensitivity in the cochlea. 
needle electrode over the ipsilateral postauricular 
area (ABR) or from an active electrode over the 
contralateral auditory cortex, with the indifferent 
needle electrode 2 mm anterior to the bregma 
(MLR). Stimuli were clicks elicited by a 0.2-ms 
voltage pulse imposed across an Etymotic Re- 
search speaker (ER-3A 10g2) which was coupled 
to the external auditory meatus. Stimuli were 
delivered at 20 / s  (ABR) or 5 / s  (MLR). Physio- 
logical responses were amplified 10,000 × (Grass 
P15 and in-house amplifier), filtered (3 H z - 3  kHz 
bandwidth) and averaged (512, ABR; 256, MLR) 
using an IBM AT-based signal processor. ABR 
and MLR input-output ( I / O )  functions were 
recorded before and after each drug administra- 
tion. 
At termination of the physiological study, 0.5 
ml of methyl blue dye was injected into the 
cochlea in 2 animals. One and a half days follow- 
ing injection, these and all other animals complet- 
ing this study were sacrificed and systemically 
perfused (4% paraformaldehyde).  The cochleas 
were decalcified (2% EDTA),  embedded in Epon, 
sectioned mid-modiolarly, stained (paragon) and 
examined under light microscopy. The extent of 
methyl dye distribution, t rauma due to surgery, 
and the presence of infection were evaluated in 
these tissues. 
Results 
In vitro studies 
The micro-injector was found to be easily au- 
toclavable. No major changes in the structure of 
the injector were observed after the autoclaving. 
A 20% shrinkage in length of the cannula was 
observed. Strength or functionality of the system 
was not obviously changed by the shrinkage of 
the tubing. Pre-autoclaving the tubing or the use 
of silicone tubing would eliminate the problem of 
the heat-induced shortening. 
Using a small screwdriver, reliable infusion of 
fixed quantities of solution was given. A mini- 
mum injection was accomplished by turning the 
screw approximately 15 ° . This was the smallest 
adjustment possible without the screw returning 
to its original position, due to hysteresis in the 
system created by the friction of the elastic rub- 
ber plunger against the sides of the injector. 
Twenty-four infusions could be delivered with 
this minimum advance with one turn of the screw. 
Each injection was 0.3-0.5 /~l. One full injector 
reliably yielded approximately 300 infusions. 
Although the inner diameter of the infusion 
tip is very small (0.005 in.), fluids of even moder- 
ate viscosity easily passed through the tip and no 
fluid was visible in the tip following infusion. 
Testing performed with the catheter infusion tip 
submerged in isotonic solutions demonstrated lit- 
tle or no diffusion in or out of the infusion tip. 
In vivo studies 
The MIS was easily implanted into the cochlea 
and secured to the animal's skull. In some ani- 
mals, a small amount of intrascalar bleeding was 
visible after drilling the hole in the lateral wall of 
the basal turn. This bleeding quickly resolved, 
possibly by constriction of the cochlear vessels 
(Hallen et al., 1974). A brief, small outward de- 
flection of the round window was consistently 
observed upon injection following implantation, 
reflecting the intracochlear volume and pressure 
changes. After infusion, the round window re- 
turned to its original position without apparent 
damage (Dohi et al., 1988) and with no observ- 
able effect on cochlear electrophysiological func- 
tion. Examination of sections of the cochlea taken 
1.5 days following infusions of methyl blue dye 
(0.5 ml) into the scala tympani indicated that the 
dye spread through the majority of the basal turn. 
While the dye was infused into the scala tympani, 
traces of the dye were also visible in the scala 
vestibuli and the scala media of the cochlea. 
Fig. 2 illustrates the acoustically evoked ( I / O )  
function of the ABR before and following 1-~1 
injection of saline. The response functions re- 
mained stable across repeated injections. We also 
observed stable acoustic ABR and MLR I / O  
response functions following implantation and 
throughout daily injections of 1 ml of saline for 
more than 1 week. Fig. 3 is a representative 
example of the MLR I / O  functions observed 
prior to and following administration of q-'TX. 
The TTX infusions reliably decreased evoked re- 
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Fig. 2. Click-evoked ABR, amplitude input/output (1/O) 
functions from 1 representative subject, recorded prior to and 
following injection of 1 ml of saline into the scala tympani 
using the micro-injector system (MIS). 
basis for approximately 3-5  h each time the drug 
was infused into the scala in all subjects. After 
injection complete recovery was observed; during 
this recovery, in spite of the presence of the 
catheter, no evidence for passive diffusion of the 
drug was observed. The MIS worked reliably for 
a period of 6-14 days after the implantation in 
the 29 animals in which it was tested. In 24 of the 
treated animals, the I / O  function observed fol- 
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Fig. 3. Click-evoked MLR, input/output (I/O) functions from 
1 representative subject recorded before and following a sin- 
gle 0.5-/.tl injection of 25 p.M tetrodotoxin into the scala 
tympani via the micro-infusion system (MIS). Recordings were 
taken at 20, 35, 65 and 270 min and 16 h following drug 
injection. 
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lowing termination of the series of daily injections 
was identical to the function observed prior to 
implantation and treatment. Terminal I / O  func- 
tions were not obtained for 5 subjects; these did 
not survive the experimental paradigm, and 2 
(including one saline subject) showed signs of 
middle ear infection. 
The 2 animals first implanted with the MIS 
showed clear drug effects, which ceased after 6 
and 8 days. These subjects were re-implanted 
with a new MIS with no decrease in auditory 
function from the surgery. The new MIS allowed 
reliable drug infusion with clear effects on 
cochlear function. 
The 24 implanted animals that completed the 
study were sacrificed after the infusion period 
and prepared for histological study. Of the 24 
implanted ears, 2 showed clear signs of labyrinth- 
itis. The ears of the remaining subjects showed no 
signs of infection. In most of the cochleas, a thin 
layer of fibrous tissue was formed where the 
infusion tip entered the lateral wall. This fibrous 
tissue growth appeared to serve as a seal, closing 
the fistula left between the infusion catheter and 
the defect in the lateral wall. In no subject was 
damage to the basilar membrane observed in the 
vicinity of the catheter tip; and vascular tissues of 
the lateral wall immediately adjacent to the de- 
fect were normal in appearance. 
Discussion 
The MIS may provide a strategy to assess the 
effect on cochlear function, of agents which re- 
quire chronic study. This approach permits study 
of agents that require repeated chronic applica- 
tion, long-term recovery functions, reproducibility 
of an effect in the same preparation and, with 
re-implantation, study of multiple agents in the 
same preparation. 
In contrast to the Elvax disk system (Pasic and 
Rubel, 1989) and the mini-osmotic pump (Fried- 
man and Shatz, 1990), the MIS does not yield a 
constant low-level drug diffusion into the peri- 
lymph, but the drug solution is infused by single- 
infusion doses. Passive diffusion of the drug from 
the catheter to the perilyrnph between infusions 
are apparently minor, as observed in the in vivo 
studies. According to the characteristics of the 
drug, and the frequency and concentration of 
infusions, drug levels in the perilymph will fluctu- 
ate significantly over time. This feature makes the 
system useful for experiments in which drug ef- 
fects are required for a restricted amount of time 
per day, but in which normal physiological condi- 
tions are required between drug doses. Moreover, 
this system permits a variable volume of drug to 
be injected at each treatment. In our experiments 
(Kingma et al., in preparation), we used TTX to 
depress acoustic and electrically evoked action 
potentials. We were able to depress the system 
significantly for a 3-h period after a single infu- 
sion. After this period, action potentials returned 
to normal and the system was excitable by normal 
physiological stimuli. For a more continuous drug 
effect with such a short-lasting agent, infusions 
may be repeated more frequently, i.e., every 2-3  
h. 
Mechanical damage to the cochlea was not a 
major factor associated with this technique. The 
hole in the lateral wall for the infusion tip is 
positioned 2 mm anterior to the round window, 
well below the basilar membrane. When inserted 
into the defect, the infusion tip position is re- 
stricted by the silastic guard, in this study 0.5 mm 
beyond the tip; however, this distance may be 
varied. One half of a millimeter consistently 
placed the tip in the middle of the scala tympani 
with no direct mechanical trauma to structures 
inside the scala. Damage to lateral wall collecting 
venules demonstrated no immediate influence on 
the physiological measures we applied. 
The micro-injector has been designed as a 
closed system that does not allow for refilling 
after implantation. This is an advantage in that 
sterility of the solution is assured. Moreover, if 
the system is refillable, pressure changes inside 
the system would be difficult to avoid during 
refilling. In addition to diffusion of drug during 
refilling, these pressure changes could also dam- 
age cochlear structures. On the other hand, the 
disadvantage of this design is that effective drug 
life in solution is a limiting factor for some stud- 
ies and it is difficult to test multiple agents in the 
same preparation. Moreover, part of the system is 
implan ted  u n d e r  the animals  skin and  the other  is 
embedded  in denta l  acrylic that  is in direct con- 
tact with the skull. Thus,  most  of the drug solu- 
t ion is kept  in solut ion at or nea r  body tempera-  
ture. Some drugs, when  kept  in solut ion will 
degrade  quickly at these t empera tu res .  As 
demons t ra ted ,  however, r e - implan ta t ion  of the 
MIS can be per formed to replace the drug u n d e r  
study. 
In  our  exper iments  saline was used as the 
carrier.  The  turnover  of the peri lymph,  in combi-  
na t ion  with the relatively small a m o u n t  of saline 
infused,  led to no detectable  effect of the vehicle 
on cochlear  funct ion.  Sterile artificial per i lymph 
obviously may be a be t te r  a l ternat ive for future  
long- term studies. Dur ing  infusion of the solu- 
tion, the volume of the per i lymph will increase.  
This volume increase is reduced  in a short time, 
in part  because  of the pa ten t  na tu re  of the 
cochlear aqueduct  in the gu inea  pig, which per- 
mits per i lymph to move into the CSF. The  effect 
of flow in the opposi te  direct ion when  a fistula is 
made  in one of the scala is well documen ted  
(Moscovitch et al., 1973; Des ja rd in -Giasson  et al., 
1985; Ohyama  et al., 1988). 
The re  was no significant change  observed in 
the A B R / M L R  I / O  funct ions  before  and  after 
implan ta t ion  and after repea ted  infusion periods. 
This indicates  that  a small defect may be made  in 
the lateral  wall and  drug solut ions may be infused 
on a daily basis, with no major  change  in the 
physiological characterist ics of the system as mea-  
sured by these responses.  
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